SelectScience InterviewsLife Sciences
IRIDICA: Transforming Infectious Disease Diagnostics for Critically Ill Patients
5 Aug 2014
In this exclusive interview, Deepak Nath, President of Abbott Molecular, introduces the brand new IRIDICA system for diagnosing infectious disease. This state-of-the-art system, currently under development and based on mass spectrometry technology, has the potential to change the way that physicians diagnose serious infections.
About the company
SelectScience
Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.
